SARS-CoV-2
Showing NaN - NaN of 8
SARS-CoV-2, COVID-19 Trial in Palo Alto, Seattle
Active, not recruiting
- SARS-CoV-2
- COVID-19
-
Palo Alto, California
- +1 more
Mar 13, 2023
COVID-19, Coronavirus, SARS-CoV-2 Trial in United States (pathogen reduced SARS-CoV-2 convalescent plasma, Placebo)
Completed
- COVID-19
- +2 more
- pathogen reduced SARS-CoV-2 convalescent plasma
- Placebo
-
Little Rock, Arkansas
- +25 more
Oct 6, 2022
SARS-CoV-2 Trial in Atlanta, Seattle (mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- mRNA-1273
-
Mesa, Arizona
- +14 more
Aug 31, 2022
COVID-19, SARS-CoV-2, Furin Trial in India, Ukraine, United States
Recruiting
- COVID-19
- +4 more
-
Jacksonville, Florida
- +8 more
Aug 11, 2022
COVID-19, SARS-CoV-2 Trial in United States (Ascorbic Acid, Hydroxychloroquine Sulfate, Azithromycin)
Terminated
- COVID-19
- SARS-CoV-2
- Ascorbic Acid
- +4 more
-
Chicago, Illinois
- +5 more
Jul 12, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
COVID-19, Corona Virus Infection, SARS (Severe Acute Respiratory Syndrome) Trial in United States (Hydroxychloroquine Sulfate,
Completed
- COVID-19
- +3 more
- Hydroxychloroquine Sulfate
- Ascorbic Acid
-
Los Angeles, California
- +7 more
Dec 14, 2021
SARS-CoV-2-specific Immunity in Individuals Who Have Recovered
Active, not recruiting
- SARS-CoV-2
- COVID-19
- Sample collection
-
Birmingham, Alabama
- +52 more
Sep 3, 2021